| | Publication Year | Title | Author(s) |
| 1 | 1-Feb-2013 | Advanced glycation end products augment experimental hepatic fibrosis. | Goodwin, Michelle; Herath, Chandana B; Jia, Zhiyuan; Leung, Christopher ; Coughlan, Melinda T; Forbes, Josephine M; Angus, Peter W |
| 2 | 14-Sep-2009 | Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. | Lubel, John S; Herath, Chandana B; Tchongue, Jorge; Grace, Josephine A ; Jia, Zhiyuan; Spencer, Karen; Casley, David J; Crowley, Peter; Sievert, William; Burrell, Louise M ; Angus, Peter W |
| 3 | 6-Dec-2013 | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | Leung, Christopher ; Herath, Chandana B; Jia, Zhiyuan; Goodwin, Michelle; Mak, Kai Yan; Watt, Matthew J; Forbes, Josephine M; Angus, Peter W |
| 4 | 23-Apr-2009 | Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. | Herath, Chandana B; Lubel, John S; Jia, Zhiyuan; Velkoska, Elena; Casley, David J; Brown, Lindsay; Tikellis, Christos; Burrell, Louise M ; Angus, Peter W |
| 5 | 2-Apr-2007 | Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. | Herath, Chandana B; Warner, Fiona J; Lubel, John S; Dean, Rachael G; Jia, Zhiyuan; Lew, Rebecca A; Smith, A Ian; Burrell, Louise M ; Angus, Peter W |